Case Report
Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications
Table 3
YMRS scores for our patient in relation to day of loxapine use.
| Day of loxapine use | Dose of loxapine | YMRS score |
| 1 | 10 mg QHS | 49 | 2 | 10 mg QHS | 49 | 3 | 10 mg QHS | 49 | 4 | 10 mg BID | 50 | 5 | 10 mg QAM, 20 mg QHS | 49 | 6 | 10 mg QAM, 20 mg QHS | 49 | 7 | 20 mg BID | 48 | 8 | 20 mg BID | 44 | 9 | 20 mg BID | 49 | 10 | 20 mg BID | 42 | 11 | 20 mg BID | 40 | 12 | 20 mg BID | 34 | 13 | 20 mg BID | 38 | 14 | 20 mg BID | 30 | 15 | 20 mg BID | 26 | 16 | 20 mg BID | 32 | 17 | 20 mg BID | 30 | 18 | 20 mg BID | 34 | 19 | 50 mg QHS | 40 | 20 | 50 mg QHS | 40 | 21 | 50 mg QHS | 40 | 22 | 50 mg QHS | 38 | 23 | 50 mg QHS | 37 | 24 | 50 mg QHS | 37 | 25 | 50 mg QHS | 38 | 26 | 50 mg QHS | 35 | 27 | 50 mg QHS | 35 | 28 | 50 mg QHS | 35 | 29 | 50 mg QHS | 35 | 30 | 50 mg QHS | 40 | 31 | 50 mg QHS | 40 | 32 | 50 mg QHS | 38 | 33 | 50 mg QHS | 40 | 34 | 50 mg QHS | 35 | 35 | 50 mg QHS | 37 | 36 | 50 mg QHS | 37 | 37 | 50 mg QHS | 37 | 38 | 50 mg QHS | 39 | 39 | 50 mg QHS | 35 | 40 | 50 mg QHS | 37 | 41 | 50 mg QHS | 35 | 42 | 50 mg QHS | 35 | 43 | 50 mg QHS | 38 | 44 | 50 mg QHS | 36 | 45 | 50 mg QHS | 37 | 46 | 50 mg QHS | 35 | 47 | 50 mg QHS | 38 | 48 | 50 mg QHS | 36 | 49 | 50 mg QHS | 36 | 50 | 50 mg QHS | 36 | 51 | 50 mg QHS | 37 | 52 | 50 mg QHS | 37 | 53 | 25 mg QAM, 50 mg QHS | 37 | 54 | 25 mg QAM, 50 mg QHS | 37 | 55 | 50 mg BID | 37 | 56 | 50 mg BID | 31 | 57 | 50 mg BID | 32 | 58 | 50 mg BID | 35 | 59 | 50 mg BID | 35 | 60 | 50 mg QAM, 75 mg QHS | 32 | 61 | 50 mg QAM, 75 mg QHS | 28 | 62 | 50 mg QAM, 75 mg QHS | 25 | 63 | 50 mg QAM, 75 mg QHS | 17 | 64 | 50 mg QAM, 75 mg QHS | 8 | 65 | 50 mg QAM, 75 mg QHS | 8 |
|
|
mg: milligrams; QHS: at bedtime; QAM: every morning; BID: twice daily; YMRS: Young Mania Rating Scale.
|